and everyone, afternoon, joining you today. thank Good for us Louisa. Thanks,
some providing business call, comments by and this I will highlights. start opening For
commentary, results Q&A. we will the additional financial detail our before my regarding call Following provide Mike open to
commercial our continue as solid with move plans. execution to to the forward priorities a start and year had we strategic We
team These $XX.X revenue. total growth XX% technology adoption revenue first the quarter. were delivered instrument results by overall CleanFlow year-over-year increased of Our procedure higher our for driven and million in of
the key another of installed achievement milestone, consoles on a our This our the X,XXX GentleWave significant that in base. the we of treated being last patient comes in procedure. first In surpassing heels X year, quarter, achieved over with December millionth
in with strides revolutionize the We our acceptance root both are believe of market and thrilled to technology. and innovation are increase canal making clinical we achievements signal therapy adoption the
X,XXX compared As units of we March approximately units XX, XXX XXXX. the to In as GentleWave was of approximately March sold GentleWave's base XX, quarter, ending installed XX consoles. first
a of GX to last higher the ASP. launch our mix GentleWave led strong doctors higher-volume October, interest well practices. as the in system systems we've This from next-generation has prospective GX to relative customers, console existing those particularly Following seen of GX as higher and
GX progressing oversight assemble an well, third-party sales greater manufacturing. us of supply our initial GentleWave GX, to in To is support strong. expected that working assembly we're growth launch the team to partner demand The remains reports transfer our pipeline from the currently and our our we control and the believe GX give console. and where facility, the Hills enable We in GX this Laguna more will chain stages of that launch the
ensure margin and term. the Additionally, growth a that efficiencies in-market responses will think in allow as feedback console product. accelerate delivery maintaining while installation to near will timely and iterative our co-locating as development and benefits improvements to customer to product well and product This facilitate satisfaction improvement assembly us we produce with will
increase $X.X million, for sales a representing instrument procedure year-over-year. for third As saw totaling XX% sales, we quarter
inventory as some ahead the this of will the surplus of figure that in normalize increase effective second believe purchase we're somewhat significant in price jump February While the we that quarter was by a encouraged X. consumables, customers
fourth CleanFlow considerable PI benefits XXXX driven to our in among from were to pricing conversion consumable margin, gross our The our the program XX% new increase operating in PI improving sequentially to We was increase rates efficiencies to see by production XX% customers, of quarter line. pleased a in QX. and our
profile. As his the improving single to Mike beyond. committed provide growth scale continue more a our instrument, company we'll gross to able further XXXX in throughout and to metric color this later in we comments. towards be procedure recognize remain will margin We
installed in President, on med thrilled chain with welcome Boston of Vice at to incredible earlier over base supply tech strong Vascular margins such in optimization record and gross and focus manufacturing global Systems. this leadership American time combined pivotal with brings and operations supply we a track the as him he support. and improvements, at John improving to has experience spent Abbott including his team be operational Scientific, margins, growing chain our to performance space companies Medical Operations. XX are as John John's Relating role the to and Sonendo years McGaugh proven gross will month in
of tooth and customers stations. full a hosting and CleanFlow in American able extracted booth, had the both were Last drive Association coming the combined hands-on In experience first many of procedure perform our out conference. excitement on privilege GentleWave Endodontists Attendees in the by an were GX the of products meetings for encouraged leading time. this the the were week, have benefits connect with at to and of offering able the we industry to test Chicago our
always are commercial canal of who for perform their the the majority serves endodontists root our at with treatments. with It we on important focus conference. therapy fundamental reminder of reception pleased an strategy We the get AAE our as
the and is key support of X,XXX penetration, and and significant runway to specialty, training in United upon endodontic represent into the continue there sell Based still invest in market leaders clinicians. we in They current to education States will practices the clinical these Canada. in
root performing exists practitioners the that canals the are market recognize in the Canada. opportunity U.S. general and all same time, with who the At of XX% we also approximately
expand practice. begun second have initial commercial This of of the rollout of a half out to stages pipeline within as of early adopters. canal GPs a strategy perform builds measured who year our this into the the further their team treatment sales high will volume root We
these introducing both we seeing clinical As outcomes GentleWave positive we're reception begin and to clinicians, to propositions. the value
support a the and As on begun to seminars among this program endodontists our forward look alike. We GPs GentleWave KOLs we've maintaining both part GPs XXXX are practice. throughout best high and their of committed to a up GP can strategy service in professional and ramping level with developing and of to with to practices network, our hosting capitalize educational bring efficiency establishing
foresee the detailed move like performance, business. the we macroeconomic more at the financial implications look for around some a Before commentary our near-term and I'd into to we provide environment
believe market this this historic Over lags first hesitancy the and of Practitioners we time the cycle are quarter into may pressures choose lengthening to while been last QX. quarter. incentives, to takes to result the cycle. evidenced we've the environment, year-end environment that quarters, the the wherein inflationary proceed creating are in highlighted sales in for as capital a first quarter capital placements several Sonendo, the some And it given uncertainty tax has fourth console of current as that equipment extend in invest a our macro around by
customers' more As are systems hospital purchasers rather in centers owners you typically than businesses. or small see our with personal large a tech weighing corporation, equipment is, ambulatory more business look med capital other than in decision at one than many our see the Therefore, consumer-based more surgery process specialties. other large ways, mindset med customer a might multisite base, common that we tech
dynamics of recognized year, endodontists by the in back and to investing some particularly interest expect of half However, fully we and the to in rates our efficiencies do these able lessen are as normalize appreciate GPs technology. the
team capital believe of macro pipeline And a position of high-quality maintains remains Sonendo sales opportunities significant strong us. a despite I leads. to growth side seize Our in some the is robust pressures upon the before some facing,
We each performance growth asking and financial clearance, of the we in between regulatory market next to CleanFlow benefit for XX are and several our adoption briefly before months, of discuss share. these our XX practitioner rates the to general capture that expanding we Mike further to the to initiatives interior anticipate CleanFlow I'll have presence quarter. poised review the catalysts leveraging
improve directly components to contributes mid-XXXX. instrument from model across is procedure to highlighted is adoption procedure pivotal PI As full our CleanFlow single on while the incentivizes the which efficiency We a still CleanFlow for cases profile pricing an to margin also costly higher to anticipate incorporates improvement CleanFlow boosting a by allows before, our bottom strategy utilization. all manufacture, less line. significantly increased instruments renewed conversion we've fewer use and legacy of The further, operatory revenue. into and
sequential were figure XX%. of And in adoption. PI Our committed fourth approximately over improvement sales of quarter the sales was first remains driving a all that where unit XX% to team the quarter, CleanFlow, XXXX,
market As for considerably We dentists opens the refer over Canada there the out majority believe proposition the we the months. efficiency next a By XX XX value efficacy capture highly to need highlighting to and cohort, Sonendo in are States we XX,XXX the revenues do segment their fraction only this as believe GentleWave of GP within of of a canal the significant to system United that this addressable GP evident. increase not market becomes rollout, the opportunity and root cases. over for the
believe and initial trend that have the continue. this We've received high-volume outstanding will from using GentleWave feedback started accounts
addressed with service and to quality plan same As and rollout the maximize earlier space my is the remarks, in level in we endodontic strategic to GP to implement associated ensure the space. order and measured prepared in Sonendo a that of oversight
instrument capture on able much part CleanFlow And very efficiency teeth anterior of the believe any perform practice. of canal Anterior to approximately And PI finally, we for their this the a more cases. in meaningful this CleanFlow. for development while root of middle teeth further have a of currently year. to root tooth procedure procedure to the be of doctors XX% teeth, is instrument ability we're we The with increase the of to for the ability our that canal XX% to market looking single has and commercialization a we'll anterior represent a through forward
procedures excited opportunities PI, greatly We'll provide even dedication With and our far. further we'll on We're inflection. commercial and anterior about team's I'm a able enjoy further thus for us, strategy future economies many our will call. one single ahead margin of of hard to improve, proud growth be the of scale our on work details and
to I turn over call Watts, our quarterly performance Mike? that, With Officer, Sonendo's will Chief Financial the Michael discuss numbers. to